Stay updated on Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.

Latest updates to the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page
- Check10 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, signaling a new version of the page. This update does not modify the study data or content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new Revision: v3.6.4 line appears, replacing the previous v3.6.3. This signals an updated revision of the page.SummaryDifference0.0%

- Check31 days agoChange DetectedThe study record now shows termination with an early stop for business reasons and a new termination date, replacing prior active recruitment details. This reflects the current status of PATHFNDR-1 on ClinicalTrials.gov and indicates enrollment and ongoing results are no longer expected.SummaryDifference0.3%

- Check45 days agoChange DetectedThe study documents revision was updated from v3.6.2 to v3.6.3, indicating a refreshed protocol and related documents. This reflects an updated version of the study paperwork used by investigators.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page shows Revision: v3.6.2, replacing v3.6.0, indicating a version update to the page rather than a substantive content change.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now states that recruitment has ended and adds new sections on how to read a study record, common questions, and how to join. The heading formatting for Intervention/Treatment was updated from 'Intervention / Treatment', and the page revision is updated to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.